Medicare does pay for drug and alcohol rehab, but the way it pays looks nothing like a typical private insurance plan, and that difference trips up a lot of families searching for care for an aging parent or for themselves. Medicare splits addiction treatment across three separate parts, each with its own rules, its own costs, and in one important case, a requirement that catches almost everyone off guard.
This is the detail that causes the most confusion. Original Medicare does not have a dedicated "residential rehab" benefit the way private insurance does. Instead, Medicare Part A covers inpatient substance use treatment when it happens inside a general hospital or a Medicare-certified psychiatric hospital. The freestanding residential treatment centers that dominate search results and treatment marketing, the kind with private rooms, wellness amenities, and 30 or 60-day stays, are frequently not licensed as hospitals, and Medicare will not pay for a stay there the way it would for a hospital-based program.
If a facility is not hospital-affiliated, Medicare beneficiaries typically need to look at hospital-based detox and inpatient psychiatric units, or shift toward the outpatient side of Medicare's coverage instead. This single distinction is why so many families searching for Medicare-covered rehab end up confused when a facility they liked turns out not to be Medicare-eligible at all.
| Medicare Part | What It Covers for Addiction Treatment | 2026 Cost Detail |
|---|
| Part A (Hospital Insurance) | Inpatient detox and treatment in a general or psychiatric hospital | Inpatient hospital deductible of $1,736 per benefit period, resetting after 60 consecutive days out of the hospital |
| Part B (Medical Insurance) | Outpatient therapy, individual and group counseling, intensive outpatient programs (IOP), opioid treatment program services, screening and brief counseling for alcohol misuse | Annual deductible of $283, then 20 percent coinsurance on most services |
| Part D (Prescription Drug Coverage) | Medications used in MAT, such as buprenorphine and naltrexone in oral form | Cost varies by specific plan formulary and tier |
According to Medicare's own coverage guidance, Part A inpatient psychiatric hospital coverage is subject to a 190-day lifetime limit, a cap that does not exist for other types of hospital care and does not reset. That lifetime ceiling is worth understanding early, particularly for anyone who has already used inpatient psychiatric or addiction hospitalization in the past.
Private commercial insurers, including UnitedHealthcare, Cigna, and Aetna, built their behavioral health networks around a landscape of freestanding residential treatment centers that grew rapidly over the past two decades, largely because federal parity law required commercial plans to cover behavioral health at a level comparable to medical care. Medicare's coverage rules predate much of that growth and were built on an older, hospital-centered model of psychiatric care. That gap between how the rules were written and how the addiction treatment industry actually developed is the core reason Medicare coverage looks so unfamiliar compared to what a commercially insured family typically experiences, and it is unlikely to close quickly, since changing Medicare's underlying statute requires congressional action rather than a simple regulatory update.
Medicare added intensive outpatient programs (IOPs) as a distinct, billable benefit category starting in 2024, and that expansion has continued to shape coverage into 2026. IOPs typically bundle individual therapy, group therapy, medication management, and psychoeducation into a structured multi-day-per-week schedule without requiring a hospital stay, which makes this one of the more clinically meaningful and accessible levels of care Medicare beneficiaries can access for substance use disorder. Medicare Advantage plans, which must cover at minimum everything Original Medicare covers, have extended this benefit as well.
If you have a Medicare Advantage plan (Part C) rather than Original Medicare, your specific plan, not Medicare's general rules, will govern network requirements and prior authorization. Medicare Advantage plans commonly apply prior authorization to substance use disorder treatment more aggressively than Original Medicare does, and your choice of facility is typically restricted to that plan's specific network. A small number of Medicare Advantage Special Needs Plans exist that are specifically designed around chronic substance use conditions, though according to insurance industry analysis these remain limited in availability and are not offered in every region.
Substance use disorder in older adults is often driven by different patterns than in younger populations, frequently involving prescription medications like benzodiazepines or opioids originally prescribed for legitimate pain or anxiety management rather than illicit drug use. That distinction matters clinically, since withdrawal management for long-term benzodiazepine or opioid use in an older adult carries different medical risk than withdrawal in a younger, otherwise healthy patient, and it often requires closer medical supervision than a standard outpatient program can provide. For a closer look at how this plays out, see our coverage of prescription drug misuse among older adults, and our directory of treatment programs built specifically for older adults.
Because Medicare's addiction treatment coverage is unusually rule-bound compared to commercial insurance, verifying benefits before admission matters even more. Before committing to any program, confirm:
- Whether the facility is Medicare-certified, and specifically whether its inpatient services are hospital-based (required for Part A coverage)
- Whether you have Original Medicare or a Medicare Advantage plan, since network rules differ substantially
- How many inpatient psychiatric hospital days you have already used against your 190-day lifetime limit
- Whether the facility offers IOP as a Medicare-billable service if a hospital stay is not clinically necessary
- Whether your Part D plan's formulary covers the specific MAT medication your care team recommends
If you are weighing whether a hospital-based inpatient stay or a Part B outpatient track makes more sense clinically, our inpatient versus outpatient rehab guide breaks down how that decision is typically made, and you can browse Medicare-relevant outpatient treatment listings directly.
| Factor | Original Medicare (Parts A and B) | Medicare Advantage (Part C) |
|---|
| Provider choice | Any Medicare-certified provider nationwide | Limited to the plan's specific network, which varies by region and carrier |
| Prior authorization | Less common, though hospital-based inpatient care still involves medical necessity review | More frequently required, particularly for residential and PHP levels of care |
| Out-of-pocket structure | Standard deductibles and 20 percent coinsurance apply the same way nationwide | Costs vary by plan; some Medicare Advantage plans offer lower cost-sharing in exchange for a narrower network |
| IOP coverage | Covered as a defined benefit category since 2024 | Must cover at least what Original Medicare covers, and some plans expand on it further |
Neither option is automatically better for addiction treatment specifically. Original Medicare offers broader provider access, which matters if the closest Medicare-certified hospital-based program is not in a Medicare Advantage plan's network. Medicare Advantage can offer lower out-of-pocket costs and sometimes additional supplemental benefits, but usually at the cost of a smaller, more tightly managed provider network and more prior authorization friction for higher levels of care.
Consider a 68-year-old on Original Medicare who has developed an opioid use disorder following an extended prescription for chronic pain after surgery. Because their withdrawal risk is medically significant and they have cardiac history that complicates unsupervised detox, their physician determines inpatient hospital-based detox is medically necessary. That care is billable under Part A, subject to the inpatient hospital deductible, and once stabilized, the same patient can transition to a Part B-covered IOP or standard outpatient MAT program for ongoing treatment, with buprenorphine covered under their Part D plan. Compare that to a 70-year-old on a Medicare Advantage plan with the same clinical picture. Their care team must first confirm the plan's specific network includes a hospital-based detox facility, and depending on the plan, prior authorization may be required before that admission is approved, adding a step that Original Medicare's hospital coverage does not always require in the same way.
Search results for "cost of rehab with Medicare" often cite wildly different numbers, and the reason is that most of those figures are pulled from private-pay or commercial-insurance pricing at freestanding residential centers, which is not the pricing structure Medicare beneficiaries are usually working within. Because Medicare pays hospital-based providers according to its own fee schedules rather than a facility's private-pay rate card, a Medicare beneficiary's actual out-of-pocket cost is generally far more predictable, and often far lower, than headline rehab cost figures suggest, provided the facility is properly Medicare-certified. This is one more reason confirming hospital-based, Medicare-certified status before admission matters as much as confirming clinical fit.
Medicare does provide real, usable coverage for addiction treatment, and the 2024 expansion of IOP benefits made that coverage meaningfully more accessible heading into 2026. But it works through a structure built around hospitals and medical necessity rather than the freestanding residential model most treatment marketing describes, so the most important first question to ask any facility is not "do you take Medicare," but "are you Medicare-certified as a hospital-based provider for the level of care I need." Once that is confirmed, comparing inpatient and outpatient paths becomes a much simpler, clearer decision.
Frequently asked questions
Only if the facility is licensed as a hospital or Medicare-certified psychiatric hospital. Many freestanding residential treatment centers do not meet this requirement, so Medicare beneficiaries should confirm hospital-based status before assuming coverage applies.
Part A requires a $1,736 inpatient hospital deductible per benefit period in 2026. Part B requires a $283 annual deductible plus 20 percent coinsurance on most outpatient behavioral health services. Exact costs vary based on the specific services used.
Yes. Medicare Part A limits coverage at freestanding psychiatric hospitals to 190 days over a person's entire lifetime, a cap unique to psychiatric hospital care that does not apply to general medical hospital stays.
Yes. Medicare added IOP as a specific covered benefit category in 2024, allowing beneficiaries to receive group therapy, individual counseling, and medication management without a hospital admission.
Medicare Advantage plans must cover at least what Original Medicare covers, but they typically apply their own network restrictions and more frequent prior authorization requirements, so your specific plan's rules matter more than Medicare's general policy.
Yes. Medicare covers opioid treatment program services under Part B, and oral medications used in MAT are generally covered under Part D, subject to that plan's specific drug formulary and cost tier.
This article was reviewed by the RehabsNearMe Editorial Team for accuracy, clarity, and relevance. Information may be sourced from publicly available treatment resources, government agencies, and healthcare references where applicable.
Last reviewed: September 2026
Related articles
Resources
